4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-21-007666
Chief Scientific Officer acquired 104,310 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DECICCO CARL Chief Scientific Officer | 2021-12-09 | Option exercise | +104,310 | $3.72 | $388,033 | 362,707 | D |
| Derivatives | |||||||
| DECICCO CARL Chief Scientific Officer | 2021-12-09 | Option exercise · Stock Options (Right to buy) | −76,892 | 186,571 | D | ||
| DECICCO CARL Chief Scientific Officer | 2021-12-09 | Option exercise · Stock Options (Right to buy) | −27,418 | 34,273 | D | ||
Loading xslF345X03/primarydocument.xml…